Showing posts with label Drugs. Show all posts
Showing posts with label Drugs. Show all posts

December 4, 2009

Friday, December 04, 2009
New research from Johns Hopkins University suggests that ecstasy, or methylenedioxymethamphetamine (MDMA) use increases the risk of developing sleep apnea among healthy young adults.

What is ecstasy?

Ecstasy is a synthetic drug that causes both hallucinogenic and stimulant effects. It was developed in Germany in the early twentieth century as an appetite suppressant, but today it is consumed for its hallucinogenic and stimulant effects.

Who uses ecstasy?

Most MDMA users are teenagers or young adults. More than 10% of high school seniors have tried MDMA at least once, and more than 2% have used the drug in the past month, according to the University of Michigan's Monitoring the Future Survey. MDMA users typically come from middle- and upper-class households. MDMA is inexpensive. The average retail price of an MDMA tablet is between $20 and $30 making it attractive and accessible to younger users.

What are the potential risks of ecstasy use?

The effects produced by consuming MDMA can last for 4 to 6 hours, depending upon the potency of the tablet. Using the drug can cause confusion, depression, anxiety, sleeplessness, craving for the drug, and paranoia. Use of the drug also may result in muscle tension, involuntary teeth clenching, nausea, blurred vision, tremors, rapid eye movement, sweating, or chills. People who have circulatory problems or heart disease face particular risks because MDMA can increase heart rate and blood pressure.

What is Sleep Apnea?

Clinically significant levels of sleep apnea are defined as five or more episodes per hour of any type of apnea. There are three distinct forms of sleep apnea: central, obstructive, and complex (a combination of central and obstructive). Breathing is interrupted by a lack of respiratory effort in central sleep apnea, while breathing is interrupted by a physical block to airflow despite respiratory effort in obstructive sleep apnea. In complex (or "mixed") sleep apnea, there is a transition from central to obstructive features during the events themselves.

Obstructive sleep apnea is a serious breathing problem that interrupts your sleep. It means you have short pauses in your breathing when you sleep. These breathing pauses – called apneas or apnea events – last for 10 to 30 seconds or longer. People with obstructive sleep apnea can stop breathing dozens or hundreds of times each night.

Obstructive sleep apnea (also called OSA or obstructive sleep apnea-hypopnea syndrome) stops you from having the restful sleep you need to stay healthy. If it’s not treated, sleep apnea can lead to major health problems, accidents, and early death.

The two main symptoms of sleep apnea are:
  • You’re very sleepy during the day, but you don’t know why.
  • You snore and have pauses in your breathing while sleeping.
Some other signs and symptoms of sleep apnea are:
  • You have high blood pressure.
  • You’re irritable.
  • You gasp or choke during sleep.
  • You’re very tired (you have fatigue).
  • You’re depressed.
  • You can’t concentrate.
  • You have morning headaches.
  • You have memory problems/ memory loss.
  • For men: you have impotence (difficulty keeping an erection).
How is Sleep Apnea treated?

The best treatment for obstructive sleep apnea is continuous positive airway pressure (C.P.A.P.). CPAP is the first choice treatment for all mild and moderate sleep apnea. It's the only effective treatment for severe sleep apnea.

If you have mild or moderate sleep apnea, your doctor may recommend one of these alternate treatments instead of CPAP:
  • Making lifestyle changes: losing weight, avoiding alcohol and sedatives
  • Dental appliances
  • Surgery, including tonsillectomy and UPPP (uvulopalatopharyngoplasty)
Sleep apnea can lead to various health problems such as diabetes, heart disease, neurological problems, cognitive deficits, impulsive behaviour and altered brain wave patterns during sleep.

This study included 71 MDMA users that were recruited from newspaper and flyer ads seeking “club drug users”. The MDMA users had all used at least 25 times in their past. This amount appears to be significant enough to cause lasting effects on serotonin levels. Researchers also recruited 62 participants with similar patterns of illegal drug use. All of the volunteers were physically and psychologically healthy and had abstained from using for at least 2 weeks prior to participating in the study.

During the study subjects were hooked up to various machines that measured breathing such as air flow monitors in the nose and mouth and bands around the chest and abdomen.

“The researchers diagnosed sleep apnea by counting the rate of incidences of shallow or suppressed breathing, with mild apnea requiring five to 14 of these incidences, moderate apnea requiring 15 to 29, and severe apnea requiring 30 or more.”

Results of mild sleep apnea were similar in both groups where 15 MDMA users and 13 of the control group were affected. There were 8 MDMA users that had moderate sleep apnea and one had the most severe form of the disorder. Most shocking is that of the 24 with sleep apnea, 22 were 31 years of age or younger. The control group had no participants that fell into the moderate or severe forms of this disorder. In addition, it seems the amount of MDMA use is associated with the severity of sleep apnea as those who had used more in the past had more severe forms of the disorder.

“Though the researchers suspect that the cause for the MDMA users' sleep apnea centers on affected serotonin neurons, the exact mechanism remains a mystery. McCann explains that these neurons appear to help sense blood oxygen levels, control airway opening and generate breathing rhythms. Any of these pathways could be separately influenced by ecstasy use, she says.”

Ecstasy Use May Lead to Sleep Apnea: Illegal 'Club Drug' Poisons Neurons Involved in Control of Breathing during Sleep

Sleep Apnea

Canadian Lung Association

National Drug Intelligence Center

© www.mentalhealthblog.com

June 2, 2009

Tuesday, June 02, 2009
Former MP John Reynolds believes that Canada should start medicating addicts with prescription heroin; in the same manner it would any other health condition that is controlled with medication. Clearly, convincing Canadians of this presumption will not be an easy feat as addiction is hardly comparable to conditions like high blood pressure or diabetes.

“Mr. Reynolds, a member of the InnerChange Foundation in Vancouver, applauded the research arm of Health Canada for financing the Study to Assess Longer-term Opioid Medication Effectiveness (SALOME), which will offer heroin and a legal substitute, Hydromorphone.”

And…“In a secondary phase, some of the 200 addicts who will be recruited to the program will be offered heroin in a pill form - another way of reducing the stigma and health risks associated with injecting drugs.”

"We really hope with SALOME that, if we can show (Hydromorphone) is as effective, there will be so many fewer obstacles to treatment - because it is not called heroin."

Surely society can perceive the benefits for the addict and the community as a whole; however the pill is not the answer. The addict no longer has to commit crimes and suffer various traumas associated with obtaining drugs. The addict can be slowly weaned off drugs in a more controlled manner with the assistance of health professionals in order to ease themselves into proper treatment. The addict would have much needed support during the path to recovery.

No one can deny these benefits; however is the main objective here not to make drug use safer and reduce crime? Many people, including addicts, will view this method as replacing one drug with another, therefore maintaining psychological dependence. In addition, side effects and withdrawal symptoms are not all that unlike those of heroin, morphine or other opiods. Although studies have shown that Hydromorphone can be more successful than methadone, the latter has also not proven to be the much needed solution for many addicts.

I must say that I’m not sold on the idea that addiction is merely a physical condition needing medication, Mr. Reynolds. Recovery requires treatment of both physical and psychological aspects, especially when addiction is so often combined with other mental health conditions.

Prescribe heroin to addicts, former Tory MP says

© www.mentalhealthblog.com

February 20, 2009

Friday, February 20, 2009
The current issue of The Journal of Pain has published a guideline to assist clinicians in prescribing opioid pain medications for patients experiencing chronic non-cancer pain.

“To create this guideline, researchers in the Oregon Evidence-based Practice Center (EPC) at Oregon Health & Science University collaborated with the APS and AAPM for two years, reviewing more than 8,000 published abstracts and nonpublished studies to assess clinical evidence on which the new recommendations are based”.

An extensive literature review revealed that much research is needed in this area; however conclusive evidence suggests that opioids are safe and effective for certain patients, if carefully monitored.

The guideline consists of 25 recommendations, some of which consider the growing concerns for opioid abuse and addiction. Opioids, such as oxycontin and morphine, have gradually become more commonly prescribed and accepted for treating various sorts of pain, including chronic low-back pain, arthritis, fibromyalgia etc., whereas previously opioids were mainly used for treating pain related to post-op, cancer and death.

This new guideline insists that clinicians rule out other possible medications as treatment options before prescribing opioids. However, if it is determined that opioid medication is the ideal choice, clinicians are expected to “conduct a thorough medical history and examination and assess potential risk for substance abuse, misuse or addiction”.

It is shocking to learn that this hasn’t already been considered common practice and that a guideline had to be introduced in order to put this in place! It’s no wonder there has been such an increase in opioid abuse and misuse. Seriously, is this not a typical task for a medical doctor? It seems like a fairly important step in any type of treatment.

Subsequently, with this guideline it will ensure that clinicians “continuously assess patients on chronic opioid therapy by monitoring pain intensity, level of functioning and adherence to prescribed treatments. Periodic drug screens should be ordered for patients at risk for aberrant drug behavior”.

The American Pain Society and the American Academy of Pain Medicine have ensured that patients will be well monitored. To read more about other recommendations in this guideline regarding such topics as methadone use, high dosages, abusers, pregnancy, driving safety, and more, please view the following article: New Guideline For Prescribing Opioid Pain Drugs.

© www.mentalhealthblog.com

November 16, 2008

Sunday, November 16, 2008

“For the first time, researchers from the Institut de physiologie et biologie cellulaire (CNRS/Université de Poitiers) have shown that positive and stimulating environmental conditions make it easier to treat cocaine addiction”.

In particular, Marcello Solinas and Mohamed Jaber exposed cocaine addicted mice to an enriched environment during cocaine withdrawal. The environment consisted of small houses, a running wheel, tunnels and many other stimulating items in a large cage.

The researchers observed three measures of typical addictive behaviour:

    1. Behavioural Sensitization: the progressive augmentation of behavioural responses to cocaine that develops during repeated administration.

    2. Location Preference: the ability of the context to induce drug-seeking behaviour and strengthen the contextual association with drug use.

    3. Probability of Relapse: “cocaine's ability to lead to a relapse after a period of withdrawal.”

Results showed that all three of these typical behaviours disappeared after the mice had endured 30 days of the enriched environment. In the brain, this disappearance was seen by a decrease in activity in the specific areas associated with dopamine transmission and relapse.

Does this seem like news to anyone? Of course rehab won’t work for individuals who are thrust right back into the same environmental circumstances. The rehabilitation process should definitely include changes to living conditions. Availability of cocaine will clearly hinder the probability of relapse. The same basic routine will allow an addict to easily slide back into old habits.

Besides pointing out the obvious, this “new” research does provide a bit of insight. Addiction treatment centres may want to consider adding housing support workers to the therapeutic process. The social, physical and mental stimulation seem to be key factors in maintaining sobriety; therefore it might be beneficial to include exercise regimens and educational programs as well. The ideal solution does not seem to be spending 30 days discussing the reason you became an addict only to settle right back into the same old routine after successful completion of a program. Evidently, the emotional aspect is a necessary step in the process, but if anything, this research proves that there is more to treating cocaine addiction. It’s a complete lifestyle overhaul.

Drug Addiction: Environmental Conditions Play Major Role In Effective Treatment And Preventing Relapses, Animal Study Shows

© www.mentalhealthblog.com

August 17, 2008

Sunday, August 17, 2008

Researchers at Linköping University and the German Cancer Research Center DKFZ have discovered the possibility of preventing relapse among cocaine addicts.

Because dopamine-producing nerve cells; part of the brain’s reward system in the midbrain, become more excited with drug use, blocking their glutamate receptors could remove the risk of relapse entirely. They discovered this finding by using a mouse model of cocaine dependence.

"When you take cocaine, the number of glutamate receptors increases, rendering the cell more excitable. When we block this process, we prevent relapses into addiction. This is interesting clinically since that is the phase when we get hold of patients" says the study’s lead author and neurobiologist, David Engblom.

Dopamine becomes more concentrated in the midbrain with the use or abuse of dependence-inducing drugs, such as cocaine, which has a very rapid effect on dopamine levels in the brain. The increased concentration of dopamine produces physical and mental reactions characteristic of a "high".

To terminate this process, patients could be injected with a vaccine that would block glutamate receptors and thus prevent a relapse. It seems like a rather simplistic solution and the research is clearly in its early stages of development, however any research at all that seeks to advance the treatment of addiction is well worth mentioning and investigating further.

© www.mentalhealthblog.com

February 29, 2008

Friday, February 29, 2008
Finally, there’s more research suggesting the need to reduce the over-medicating of mental illness, specifically depression. The study conducted by Irving Kirsch of the University of Hull discovered that the benefits of anti-depressants, such as fluoxetine (Prozac), venlafaxine (Effexor), nefazodone (Serzone), and paroxetine (Seroxat / Paxil), are dependent upon the severity of the mental illness.

The study used a meta-analysis of data retrieved from trials supplied by the US Food and Drug Administration. “When the data from all of these trials had been put together, the improvement in depression amongst patients receiving the trial drug, as compared to those receiving placebo (dummy tablets), was not clinically significant in mildly depressed patients or even in most patients who suffer from very severe depression” – Article

It comes as no surprise that only a small group of participants actually benefited from their medications, and these patients tended to be those who suffered from severe depression to begin with. The severely depressed reaped fewer benefits from the placebo and more benefits from the actual medication than those less depressed. This not only suggests that anti-depressants serve their purpose for those who are really suffering, but it clearly demonstrates that not everyone needs to be medicated to function. Over-medicating is a serious problem within our society because it does seem easier to slap on a Band-Aid as opposed to working through months or even years of therapy. Unfortunately, the social and monetary cost of clinical therapy does not seem plausible for everyone in our society, however it hardly seems ethical or even productive to convert the depressed into addicts.

In my opinion, medication should always be the last resort when alternative measures are more proficient in treating mental illness.

© www.mentalhealthblog.com

February 28, 2008

Thursday, February 28, 2008
In recent news, Ottawa’s police Chief, Vern White has made some absurd statements with respect to drug dealing and welfare fraud. His force has decided to report a little over 100 drug dealers to welfare officials for fraud investigations in hopes of having them cut off social assistance. His views are portrayed in a manner that support the greater good of society by saying: “Our focus here, first of all, is to stop people from dealing drugs but secondly to ensure social assistance is provided to people for the right reasons and not for those people who continue to sell drugs and lie about their income”.

On the surface, this act appears to be appealing to the so-called tax payer, however if you glance beneath it seems that there is an ulterior motive. What impact would these sorts of headlines have? Is it really to scare the fraud out of other abusers? Is it to encourage the low-level dealers, who are likely barely surviving at the poverty level with their monthly social assistance cheque to cease taking in that extra cash under the table? Of course, fraud is never legal, but who in their right mind would report income from drug dealing. Some of these dealers may even be dealing to support a drug habit, a poverty stricken family, or even to cover a necessary medication not covered through a drug plan. Whatever the reason may be, threatening to cut their Ontario Works cheque is hardly fighting the war on drugs. Petty dealers are a dime a dozen.

The Chief may have an interesting strategy, but I hardly think he’s aiming at saving tax payer dollars. It seems that the real reason for this announcement is to coerce drug dealers into snitching on their suppliers. The president of the Defence Counsel Association of Ottawa, Mark Ertel, makes an interesting assumption: “You can either become an informant for the Ottawa police or you can be reported for committing welfare fraud”. Article

Granted this might have some impact on the drug epidemic, but the means is through blackmail. Drug dealers may not be the most upstanding citizens; however this type of strategy leaves no room for assistance for these individuals who may be suffering from addiction. Additionally, these addicts who are reported for fraud may stop milking the system, but they may begin committing other crimes to make up for that lost money.

The money these dealers make from committing welfare fraud certainly pale in comparison to the money that flows through the hands of those controlling the drug trade.

Article

© www.mentalhealthblog.com

Popular Posts

Dentalget.com is dental equipment supplier, we provide high quality dental instruments, dental handpiece at a discount price. Free shipping worldwide.

Categories

9/11 AADD Abortion Academic Success Acetylcholine ADD Adderall Addiction ADHD Adult Attention Deficit Disorder Adultery Advertising Aggression Aging Agreeableness AIDS Air Pressure Alcohol Alcohol Abuse Alcohol Dependence Alcoholism alpha-CaM kinase II Altitude Alzheimer's Amphetamine Amygdala Amyloid Amyloid Deposition Anesthesia Anger Anterior Cingulate Cortex Anterograde Amnesia Anti-Depressants Anti-Psychotic Anticholinergic Anticonvulsant Antiepileptic Antioxidants Anxiety Anxious-Avoidant Anxious-Preoccupied Apolipoprotein E Army Aromatherapy Asperger Syndrome Assessment Associative Learning Asthma Attachment Theory Attention Attention Deficit Disorder Attention Deficit Hyperactivity Disorder Autism Autism Spectrum Disorder Autonomic Nervous System Average Sleep Requirements B-type Natriuretic Peptide Babies Balance Behavioral Problems Behaviour Behavioural Impairment Behavioural Therapy Benadryl Bipolar Disorder Blood Clot Blood Pressure Blue Light Blue Light Goggles Body Mass Index Bone Marrow Brain Brain Development Brain Imaging Brain Injury Brain Stem Brain Surgery Breast Cancer Buddhism bullying Bupropion Business C-reactive Protein Calories CAMH Canada Canadian Charter of Rights and Freedoms Cancer Carbohydrates Cardiovascular Disease Care Facilities Caregiver cars Cdk5 Cell Phone Central Nervous System Centre for Addiction and Mental Health Cerebellum Cerebral Amyloid Angiopathy Cerebral Cortex Cerebrospinal Fluid Cerebrovascular Accident Cerebrovascular Insult Chat Rooms Chewing Childhood Disabilities Childhood Disintegrative Disorder Childhood Emotional Neglect Children Chitin Chitosan Cholesterol Choline Chromosome Chronic Pain Syndrome Chronic Stress Circadian Rhythm Cirrhosis Citalopram Classical Conditioning Climate Change Clot-Busting Drug Co-morbidity Cocaine Cognition Cognitive Development Cognitive Impairment Colloquially Brain Attack Coma Communication Device Communication Technology Concentration Concerta Concussion Conflict Confusion Conscientiousness Control Group Coordination Correlation Cortisol Counselling Couples CPAP Crack CRASH-2 CRASH-3 Creativity Criminal Code Cyberbullying Cyberpsychology Cyklokapron Daytrana Death Death Toll Decision-Making Declarative Memory Deep Brain Stimulation Delusion Dementia Dentures Depression Destrostat Deviant Behaviour Dexedrine Dextromethorphan Diabetes Diet Dietary Supplements Diphenhydramine Disability discrimination Dismissive-Avoidant Disorganized Attachment Disorganized Speech Disorientation Dizziness Docosahexaenoic Acid (DHA) Double-Blind Dream Drinking Drowsiness Drug Abuse Drug Dependence Drug Use Drugs DSM DSM-5 Dual Diagnosis Early Onset Alzheimer's Economic Crisis Ecstasy Effexor Ego Eicosapentaenoic Acid (EPA) Elderly Electrical Stimulation Electroconvulsive Therapy Electrodes Email Embitterment Embolic Emotion Emotional Neglect Emotional Problems Emotional Well-Being Employee Enrivonment Enzyme Epilepsy Estrogen Ethics Evolution Experimental Group Extracellular Signal-Regulated Kinase (ERK) Extroversion Facebook Facebook Fan Page Facebook Friends Family Family Therapy Fast Food Father Father Absenteeism Fatherhood FDA Fear Fearful-Avoidant FeelingBetterNow Fetus Fibrin Fish Oil fluoxetine fMRI Focalin Focus Food Fraud Friday Gamma Secretase Genetic Disorders Genetics Ginkgo Biloba Glucose Glutamate Receptor God Gout Guest Blogger Hair Pulling Haiti Hallucination Hallucinogenic Halo Effect Harm-Reduction Headache Healthy Eating Hearing Heart Attack Heart Disease Hematopoietic Stem Cells Hepatitis Hepatitis C Herbal Supplements Hereditary Angioedema Heredity Heroin High Blood Pressure Hippocampus Hockey Homelessness Hormone Housing Hox Genes Hoxb8 Cells Human Rights Hydromorphone Hyper-social Networker Hyperactivity Hypothalamus Illness Impulse Control Impulsivity Inattentiveness Infant Infidelity Inflammation Insecure Attachment Insomnia Instant Messaging Insulin Intellectual Development Intellectual Disability Internet Intracranial Bleeding Introversion Introvert Ischemic Stroke KASPAR Ketamine Ketogenic Kleptomania Laptop Latent Inhibition Learning Learning Disability Leukotrienes Limbic System Lithium Liver Locked-In Syndrome Long Term Memory Long-Term Potentiation Longevity Lupus Lysteda Maestro Rechargeable System Major Depression Mania MAOI Marriage MDMA Medication Meditation Melatonin Memory Memory Loss Memory Task Men Mental Health Mental Health Forum Mental Heath Mental Illness Metadate Metyrapone Mice Microglia Mild Cognitive Impairment (MCI) Mild Traumatic Brain Injury Military Mind-Body Mindless Eating Mitochondria MOHLTC Mood Disorder Morphine Mortality Rates MRI MS-275 Multiple Sclerosis Muscle Weakness music therapy Narcissism Natasha Richardson National Sleep Foundation Natural Disaster Nature/Nurture Nausea Necrosis Neglect Nerve Neuro-imaging Neurobiology Neurodegeneration Neurodegenrative Diseases Neurodevelopment Disorders Neurogenesis Neurological Disease Neuromarketing Neuron Neuropathy Neuroticism Neurotransmitter News Nintendo Wii Non-REM Sleep Nose Nurse Ratched Nutrition Obesity Obessive Compulsive Spectrum Disorder (OCD) Offspring Olfactory Gland OM3 Emotional Balance Omega 3 Ontario Ontario Review Board Ontario Works Opioid Oral Health Organic Ottawa Over-activity Over-Medication Ovulation Oxidative Cell Oxygen Oxytocin p35 Pacemaker Pain Pain Killer Pain Management Pancreatic Polypeptide Pancreatitis Paralysis Paranoia Paraskevidekatriaphobia Parenthood Parents Parkinson's Paroxetine Paxil PDD-NOS perception Perfume Peripheral Nervous System Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Pathway personality traits Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) PET Scan Pharmacology Phobias Physical Health Physiological Plasmin Plasminogen Plasticity Platelet-Activating Factor Politics Post-Concussion Assessment and Cognitive Test (ImPACT) Potassium Ion Channel Poverty Pregnancy Pressure Procedural Memory Promiscuity Prozac PsychBoard.com Psychiatric Ward Psychological Psychological Inventories Psychologist Psychology Psychology Forum Psychology of Eating Psychosis PTED PTSD Public Health Pyromania Quadriplegic Rehab Relationships Reliability Religion REM Research Retigabine Retrograde Amnesia Rett Syndrome Risperdal Ritalin road rage Robot Robotics Rodent Research Rosiglitazone Samsung Satiety Scales Schizophrenia School Screening Secure Attachment Sedatives Seizure Self-Affirmation Intervention Self-Confidence Self-Esteem Self-Integrity Self-Worth Semantic Memory Senior Seroquel Serotonin Serzone Sex Sex Therapy Sexual Orientation Sexual Satisfaction Shock Therapy Sideline Concussion Assessment Test (SCAT2) Sleep Sleep Apnea Sleep Disorders Sleep Quality Sleep Stages Smartphone Smoking Snacking Sniffing Technology Social Assistance Social Deficits Social Isolation Social Media Social Network Social Rejection Social Skills Social Worker Socialization Societal Change Soft Palate Soldier Somatic Nervous System Spatial Memory Special K Speech Spinal Cord Spinal Cord Injury Spinal Tap Sports Injury SSRI Statin Stem Cell Stimulant Strattera Stress Stress Hormone Stroke Substance Abuse Sugar Suicide Superstition Support Survey Suspicious Tablet Talk Therapy Tamoxifen Tanorexia Tax Payer Technology Television Telomere Temperature Testosterone Texting Therapy Thorazine Threshold Thrombosis Thrombotic Tinnitus Tissue Plasminogen Activator Topographical Disorientation Tranexamic Acid Trauma Treatment Tremors Trial Tribunal Trichotillomania Type-2 Diabetes Vagus Nerve Validity Ventromedial Prefrontal Cortex Video Games Virtual Reality Vision Visual Attention Vitamin B Vitamins Vitiligo Voice Vyvanse Walnuts Weight Loss Welfare Wellbutrin Wernicke–Korsakoff syndrome Wet Brain White Blood Cells Women Work World Health Organization Zileuton Zyban Zyprexa µ-opiate receptors (MOR)